Vivitrol 380 MG vial-diluents
Ended Awarded Last action
- Contract number
- SPE2DR26FU208
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,716
Award facts
- Contract value 100% obligated
- $13,715.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,715.91 on November 26, 2025, for the supply of Vivitrol 380 mg vials with diluents. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026 that supports global military healthcare procurement.
As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies an extensive portfolio of pharmaceutical products and medical commodities to the Defense Health Agency and other government healthcare systems. Vivitrol (naltrexone) is an FDA-approved medication used in addiction treatment and pain management, making this supply requirement consistent with the company's demonstrated capability to deliver specialty medications across multiple therapeutic domains. The delivery order's short completion window reflects the urgent nature of pharmaceutical supply requirements within the military healthcare system, leveraging the efficiency and responsiveness enabled by AmerisourceBergen's established prime vendor relationship with DLA.
Quick answers
Who was awarded contract SPE2DR26FU208?
SPE2DR26FU208 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FU208 worth?
The government has obligated $13,716 on SPE2DR26FU208.
Is contract SPE2DR26FU208 an order under another contract?
Yes. SPE2DR26FU208 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU208 competed?
The extent of competition for SPE2DR26FU208 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award